Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RASEF | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
mRNA | WDR48 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | NOC2L | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
mRNA | TESPA1 | CCLE | pan-cancer | AAC | 0.17 | 0.009 |
mRNA | SASH1 | CCLE | pan-cancer | AAC | -0.15 | 0.009 |
mRNA | FAIM2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | PRIM1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | GDF2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
mRNA | TMED2 | FIMM | pan-cancer | AAC | 0.45 | 0.009 |
mRNA | PHF1 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |